Human Embryo Gene Editing Shows Promise, Faces Ethical Hurdles

Human embryo germline gene editing technology has opened new possibilities in the scientific field. Two recently published studies have shown that human embryo DNA can be altered more precisely than before, increasing hopes that gene editing can be used to prevent hereditary diseases in the future. However, scientists have clarified that it is not yet ready for immediate clinical use, stating that many challenges remain regarding safety, scientific reliability, and ethical aspects.

So far, gene editing technology has begun to be used in the treatment of various genetic diseases. It has played an important role in saving the lives of patients suffering from sickle cell disease, some blood-related diseases, and other serious genetic problems, and in reducing their suffering. However, even though such treatments provide relief to patients, the possibility of genetic changes causing the disease in their bodies being passed on to their children remains.